Indeed, knockdown of SLC7A11 elevated ROS and decreased GSH levels [86], as well as enhanced invasive properties of glioblastoma cells [87], while its overexpression not only increases resistance to oxidative stress and TMZ [86]. The gene discussed is SLC7A11; the disease is glioblastoma.